FCMI
Foresite Capital Management II Portfolio holdings
AUM
$29.2M
This Quarter Return
-8.51%
1 Year Return
+44.84%
3 Year Return
-66.21%
5 Year Return
-37.37%
10 Year Return
–
AUM
$473M
AUM Growth
+$473M
(+166%)
Cap. Flow
+$312M
Cap. Flow
% of AUM
65.98%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
–
Reduced
3
Closed
1
Top Buys
| 1 |
10x Genomics
TXG
|
$345M |
Top Sells
| 1 |
ALDR
Alder Biopharmaceuticals, Inc.
ALDR
|
$27.2M |
| 2 |
AIMT
Aimmune Therapeutics, Inc.
AIMT
|
$2.54M |
| 3 |
Twist Bioscience
TWST
|
$2.11M |
| 4 |
Insmed
INSM
|
$713K |
Sector Composition
| 1 | Healthcare | 81.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
10x Genomics
TXG
$1.65B
| $345M | 72.85% |
+6,837,253
| New | +$345M |
|
|
AIMT
2
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $54.6M | 11.53% |
2,605,499
-121,069
| -4% | -$2.54M |
|
|
AERI
3
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $32.2M | 6.8% |
1,672,714
| – | – |
|
|
4
Insmed
INSM
$30.8B
| $16.1M | 3.41% |
915,016
-40,446
| -4% | -$713K |
|
|
EPZM
5
DELISTED
Epizyme, Inc
EPZM
| $15.4M | 3.25% |
1,488,444
| – | – |
|
|
XLRN
6
DELISTED
Acceleron Pharma Inc.
XLRN
| $7.45M | 1.58% |
188,602
| – | – |
|
|
ALDR
7
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $2.77M | 0.59% |
146,800
-1,439,420
| -91% | -$27.2M |
|
|
8
Twist Bioscience
TWST
$1.57B
| – | – |
-72,849
| Closed | -$2.11M |
|